å¼±ãã£ãã éãæªãã£ãã ä½ãç¥ããªãã¨ãã¦ã ããã¯ä½ããããªãäºã®ããããã«ã¯ãªããªãããããªzak_mustangãã¬ã¼ã³ããªblog æ¨æ¥ã®ç¶ãã ææã§ä»å ¥ããã®ã§è²¼ããã¨æã£ããããssdå çã®ã¨ããã§å ¨æå¼ç¨ããã¦ãã®ã§ãªã³ã¯ã§ã ãããå°é家ã ææçå¦ä¼ããã«ãã±ã¼ ï¼ssdâs Diaryï¼ åæpdfã®ãªã³ã¯ã¯ãã¡ãã 社å£æ³äººæ¥æ¬ææçå¦ä¼ç·æ¥æè¨ããä¸è¬å»çæ©é¢ã«ãããæ°åã¤ã³ãã«ã¨ã³ã¶ã¸ã®å¯¾å¿ã«ã¤ãã¦ã â éå»ã®æãå½ã«ãããæ°åã¤ã³ãã«ã¨ã³ã¶æµè¡ã®å®æ ããå¦ãã§ãã ãã â¡ æ°åã¤ã³ãã«ã¨ã³ã¶ã¯ããããæ°å¹´å¾ã«å£ç¯æ§ã¤ã³ãã«ã¨ã³ã¶ã¨ãªã£ã¦èª°ã§ãç½¹æ£ãããç æ°ã§ã ⢠æ°åãæµè¡ããã¨é壮年層ã®è¢«å®³ãç大ã¨ãªãã®ã«ã¯çç±ãããã¾ã ⣠æµè¡åæããä¸è¬å»çæ©é¢ã¸ã®å診è ãæ¿å¢ãã¾ã ⤠éçä¾ã«ã¯ã¦ã¤ã«ã¹æ§èºçãããç´°èæ§èºçä¾ãå¼å¸ä¸å ¨ä¾ãå¤ãè¦ããã¾ã
ãã¹ã¯ã¯ä½ã®ããã«ããã®ï¼ å¾æ¥ããã®åãã«å¯¾ããåçã¯ããã¹ã¯ã«ã¯ãã¤ã³ãã«ãäºé²ããå¹æã®ã¨ããã³ã¹ã¯ããã¾ãããããããèªåãç½¹ã£ã¦ããã¨ããä»äººã«ãã¤ããªãããã«ããã®ã§ããå³ã¨ãã±ããã§ããã§ããã ãã ãããã ã¨ä»ã²ã¨ã¤ã¢ããã¼ã·ã§ã³ãããããªã人ãããã§ããããèªåã®ããã«ãªãããªãã赤ã®ä»äººã®ãããªãã»ã»ã»ã¨ã ã§ãããèªåãææããªããããäºé²ã®ãããå¹æãã¯ã£ãããããã¨ããã¨ããã³ã¹ç¢ºç«ã«å¤§ããåãåºãã¦ãã¾ãã ï¼è±ªNew South Wales大å¦ã¨è±Medical Research Council Centre for Outbreak Analysis and Modelling at Imperial College Londonãã®çºè¡¨ï¼Emerging Infectious Diseasesï¼ã ï¼å¼å¸å¨ææçã«ç½¹æ£ããåä¾ããã家åºããµã³ãã«ã«èª¿æ»ãã
ãã¹ã¯ã¯ç§ãã¡ä¸è¬äººãããã¿ç±æ¥ã¤ã³ãã«ã¨ã³ã¶ï¼S-OIVï¼ããå®ã£ã¦ãããã®ãï¼çå£ã«è°è«ãããããªè©±ã§ã¯ãªãããããã人ã¯ããã°è¯ãã¨æã£ã¦ãã¾ããããã¢ã¡ãªã«ã®ç¾ç 管çäºé²ã»ã³ã¿ã¼ï¼CDCï¼ãçé¢ç®ãªå ±åæ¸ãåºãã¾ãããããã«çé¢ç®ãã¨ããã¨ãä¸éçãªæ¨å¥¨ï¼interim recommencationsï¼ã¨éæã£ã¦ãã¦ãä»å¾ãäºæ ãå¤ãã£ããæ°ããçºè¦ããã£ããå¤æ´ãããã¨ã示åãã¦ãã¾ããæ®éã®ãã¹ã¯ã¯ãã¾ãå½¹ã«ç«ãããN95ãã¹ã¯ã¯ç ä¿®ã»è¨ç·´ãåãã人ã§ãªãã¨æ£ãã使ããªãã®ã§å®ç¨çã§ã¯ãªããã¨ããçµè«ã®ããã§ãææè ãè£ çãããã¨ã«ããæ éãªæè¦ã§ãã ãªã³ã¯ï¼Recommendations for Facemask and Respirator Use to Reduce Novel Influenza A (H1N1) Virus Transmission. May 23,
2024å¹´8æ15æ¥ï¼æ¨ï¼ ã¦ã¯ã©ã¤ãã¨ã¬ã¶å°åºã§ç¶ãäºã¤ã®æ¦äºã¯ããã¾ä¸çã®æ ¸è»ç¸®ã®åãçµã¿ããã£ããå°é£ã«ãã¦ãã¾ããé´¨å¿ç°é·è§£èª¬å§å¡ã§ãã Qï¼ã大èãã®æµ·ãããã®ã¯ãNPTï¼æ ¸æ¡æ£é²æ¢æ¡ç´ã®è¹ã§ããã Aï¼ãNPTã¯ä¸çã®ï¼ï¼ï¼ã®å½ã¨å°åãå çããâ¼æ ¸å µå¨ãä¿æããã¢ã¡ãªã«ããã·ã¢ãä¸å½ãã¤ã®ãªã¹ããã©ã³ã¹ã®ï¼ã«å½ã«æ ¸è»ç¸®ã義åã¥ããâ¼ãã®ä»ã®å½ã«ã¯æ ¸å µå¨ã®éçºãä¿æãç¦æ¢ãã¦æ ¸ã®ä¸æ¡æ£ãæ±ãã¦ãã¾ãããã®æ¡ç´ã®ããæ¹ãè°è«ããå çå½ã®ä¼è°ããï¼æããï¼æã«ããã¦ã¹ã¤ã¹ã§éããã¾ããããã¦ã¯ã©ã¤ããã¬ã¶å°åºã§ç¶ãç·å¼µãåãã¦ãåå½ã®éã®å¯¾ç«ãåæãéç«ã¡ã¾ããã Qï¼ãã¦ã¯ã©ã¤...è¨äºãè¦ã 2024å¹´8æ14æ¥ï¼æ°´ï¼ é¦é½ã®ç§»è»¢ãç®æãã¤ã³ããã·ã¢æ¿åºã¯ãä»é±æ«ãç¬ç«è¨å¿µæ¥ã®å¼å ¸ãã建è¨ä¸ã®æ°ããé¦é½ã§éãã移転ãæ¬æ ¼çã«å§åããã¾ãã Q.ã¸ã§ã³å¤§çµ±é ã®æã£ã¦ããå°å³ã«ãããµ
ãã®ææ¸ã¯æ°åã¤ã³ãã«ã¨ã³ã¶A(H1N1)ã¦ã¤ã«ã¹ã®çºçãã³ãã¥ããã£ã¼ã¬ãã«ã§å ±åãããå°åã«ããããã¹ã¯ä½¿ç¨ã®æ«å®çãªæå¼ããæä¾ãããä»å¾ãæ°ããªãã¼ã¿ãå ¥ã次第æ´æ°ããäºå®ã§ããã èæ¯ ç¾å¨ãæ°åã¤ã³ãã«ã¨ã³ã¶A(H1N1)ã¦ã¤ã«ã¹ã®ããï¼ããææã®ä¸»ãªæ ¹æ ã®ããææçµè·¯ã¯ãä¼è©±ããããã¿ã¾ãã¯å³ã«ãã£ã¦æ¾åºãããå¼å¸å¨é£æ²«çµç±ã§ãããã¨ã示åããã¦ããã ã¤ã³ãã«ã¨ã³ã¶æ§çç¶ï¼ç±ããããã¿ãå³ã鼻水ãæªå¯ãçèçãªã©ï¼ããã人ã¨æ¿åæ¥è§¦ï¼ç´1ã¡ã¼ãã«ï¼ããã£ã人ã¯ãæææ§ã®ããå¼å¸å¨é£æ²«ã®æé²ã«ããææãªã¹ã¯ãããã å¼å¸å¨ã¦ã¤ã«ã¹ã®æææ¡å¤§äºé²ã®è©ä¾¡ãããç 究ã«ããã¨[2]ãå»çæ©é¢ã«ããã¦ã¯ããã¹ã¯ã®ä½¿ç¨ãã¤ã³ãã«ã¨ã³ã¶ã®ææã®ä¼æãæ¸å°ãããå¯è½æ§ã示ããã¦ãããå»çæ©é¢ã«ããããã¹ã¯ä½¿ç¨ã®å©è¨ã¯ãæ£ãããã¹ã¯ã®ä½¿ç¨ã®ãã¬ã¼ãã³ã°ãå®æçãªä¾çµ¦ãåã³é©æ£ãªå»æ£æ½è¨ã¨ãã£ã
ä»æ¥ã¯ç¯å°çéãæ©ãã¦ããããå ±éã大å¢ããã®ã§ããæ°åã¤ã³ãã«æ£è é¨ããããï¼ãã¨æã£ããèè·¯å å½éç é¢ã®å°å ç§ã訪åãããç¾æºåçåã¨ãã®ãä¸è¡ã§ããã çªãéãæ°ããã«æãæ¯ããè»ãããããã£ãç¾æºåãã¾ã¯ããã¹ã¯ã¯ãã¦ãã¾ãããããè¿ãã®æ¥éåå çã»ç¦äºå çã»ç´°è°·å çãSPã®çãããå¨å²ã®ãã©ã³ãã£ã¢ãã¡ãã£ã¢ããã¹ã¯ã¯ãã¦ãã¾ããã§ããã çå¾ãA/H1N1é½æ§ã¨ããã£ãå¦æ ¡ã®æ ¡é·å çï¼ã¤ã³ã¿ãã¥ã¼ããã¡ãã£ã¢ããã¨ãã¨ããã¹ã¯ãã¤ãã¦ããã®ã¯ãã³ãããã¼ã¨ããããã¦ãããã¾ããã æ¬é¡ã§ãããä»ã®å½ã¯ä¸è¬ã®äººã«ãã¹ã¯æ¨å¥¨ããã¦ãã¾ããã ãªã¼ã¹ãã©ãªã¢ããªã¹ã¯ãããã5ã¤ã®æ¹æ³ããã¹ã¿ã¼ã«ããã¹ã¯ã¯ããã¾ããã http://www.pandemic.tas.gov.au/__data/assets/pdf_file/0015/62340/Protect_yourself_fr
ã¤ã³ãã«ã¨ã³ã¶ãæµè¡ã£ã¦ããä»æ¥ãã®é ã§ãããè¡ã§ããã¹ã¯ããã¦ããæ¹ãããè¦ããã¾ãããã 2008å¹´ã®æ¥æ¬ã®ãã¹ã¯å¸å ´ã¯ããªãã¨300ååè¦æ¨¡ã ããã§ãããããã§ããã ã¡ãªã¿ã«ã欧米ã§ã¯ããã¹ã¯ããã¦å¤ãæ©ã人ãªãã¦ãã¾ãããããã¯æ¥æ¬ãªã©ã¢ã¸ã¢ã ãã®æåãªãã§ãã ããã§è¡æã®äºå®ããä¼ããã¾ããããå¤ãã®æ¹ã風éªäºé²ã«ãã¹ã¯ããã¦ããã¨æãã¾ãããå®ã¯ãã¾ãæå³ãªããã§ãããããã ã¨è¨ãã¨ãã¡ãã£ã¨èª¤è§£ãæããããããªãã®ã§ããã£ãã説æããã¾ãããã ä»®ã«ã空æ°ä¸ã«å«ã¾ããéèã100ã¨ãã¾ããããã§ãããã¹ã¯ããã¦ããã®æ°ã¯84ç¨åº¦ã¾ã§ããæ¸ãã¾ãããã¤ã¾ãã»ã¨ãã©æå³ããªããã§ãã ã©ãããäºãã¨ããã¨ããã¹ã¯ã«ã¯ééãããããããã®ã§ããããããã£ã«ã¿ã¼ãéããªã空æ°ãã©ãã©ãå ¥ã£ã¦ãã¦ãã¾ãã¾ããæè¿ã®ãã¹ã¯ã¯ããèãããã¦ãã¦ããª
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}